What does Eikon Therapeutics, Inc. do?
Eikon Therapeutics, Inc., operates as a clinical biopharmaceutical company in the United States. It develops medicines to address serious unmet medical needs. Its products include EIK1001, a systemically administered TLR 7/8 dual-agonist designed to activate innate and adaptive immune anti-tumor responses; EIK1003…
What is Eikon Therapeutics, Inc.'s P/E and P/B ratio?
Eikon Therapeutics, Inc. has a P/E ratio of -1.0 and a P/B ratio of 0.96.
What is Eikon Therapeutics, Inc.'s debt-to-equity ratio?
Eikon Therapeutics, Inc. has a debt-to-equity ratio of 0.54.
How much does Eikon Therapeutics, Inc. owe compared with what it owns?
Eikon Therapeutics, Inc. owes $0.40 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Eikon Therapeutics, Inc.'s Positivity rank?
Eikon Therapeutics, Inc. is ranked #2,629 of 6,774 companies globally and #896 of 4,000 in United States on PositoAI, with a Positivity Score of 21,307.
Does Eikon Therapeutics, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Eikon Therapeutics, Inc..
Where can I read the latest news about Eikon Therapeutics, Inc.?
Recent headlines about Eikon Therapeutics, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Eikon Therapeutics, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Eikon Therapeutics, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.